Search company, investor...

Biosystems International

biosys-intl.com

Founded Year

2004

Stage

Grant | Alive

Total Raised

$2.76M

Last Raised

$60K | 8 yrs ago

About Biosystems International

Biosystems International is a biotechnology company engaged in protein biomarker R&D using a unique and proprietary monoclonal antibody based proteomics technology.

Headquarters Location

Nagyerdei Krt. 98.

Debrecen, 4032,

Hungary

+36 52 322 733

Missing: Biosystems International's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Biosystems International's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Biosystems International

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Biosystems International is included in 1 Expert Collection, including Omics.

O

Omics

1,267 items

Companies involved in the capture, sequencing, and/or analysis of genomic, transcriptomic, proteomic, and/or metabolomic data

Biosystems International Patents

Biosystems International has filed 1 patent.

The 3 most popular patent topics include:

  • Auschwitz concentration camp personnel
  • Biological warfare
  • Drug discovery
patents chart

Application Date

Grant Date

Title

Related Topics

Status

12/19/2019

Human subject research, Medical ethics, Drug discovery, Auschwitz concentration camp personnel, Biological warfare

Application

Application Date

12/19/2019

Grant Date

Title

Related Topics

Human subject research, Medical ethics, Drug discovery, Auschwitz concentration camp personnel, Biological warfare

Status

Application

Latest Biosystems International News

Biosystems 
International
 se refinance

Feb 5, 2023

Biosystems International se refinance - 3 conseils La biotech développant un test diagnostic du cancer du poumon signe un troisième tour de 2,1 M€... La biotech développant un test diagnostic du cancer du poumon signe un troisième tour de 2,1 M€, majoritairement auprès de ses actionnaires historiques, dont Amundi PE.Biosystems International (BSI) signe son troisième tour. Cette biotech employant trente personnes entre Evry et la Hongrie, spécialisée dans la découverte de diagnostics innovants à base d’anticorps monoclonaux, vient de réaliser une augmentation de capital de 2,1 M€. Celle-ci a été majoritairement abondée par Amundi PE actionnaire (...) Cet article est réservé à nos abonnés. 83% reste à lire Pour accéder à cet article, à l'ensemble du site ainsi qu'à nos bases de données, découvrez nos formules d'abonnement .

Biosystems International Frequently Asked Questions (FAQ)

  • When was Biosystems International founded?

    Biosystems International was founded in 2004.

  • Where is Biosystems International's headquarters?

    Biosystems International's headquarters is located at Nagyerdei Krt. 98., Debrecen.

  • What is Biosystems International's latest funding round?

    Biosystems International's latest funding round is Grant.

  • How much did Biosystems International raise?

    Biosystems International raised a total of $2.76M.

  • Who are the investors of Biosystems International?

    Investors of Biosystems International include Horizon 2020.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.